Parallax Volatility Advisers, L.P. Vertex Pharmaceuticals Inc Transaction History

Parallax Volatility Advisers, L.P.

$45.1 Billion
Q2 2024

A detailed history of Parallax Volatility Advisers, L.P. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 7,556 shares of VRTX stock, worth $3.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,556

Previous 8,962 15.69%

Holding current value

$3.8 Million

Previous $3.75 Million 5.47%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $552,290 - $682,655	-1,406 Reduced 15.69%	7,556 $3.54 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $281,306 - $307,795	690 Added 8.34%	8,962 $3.75 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $2.84 Million - $3.4 Million	8,272 New	8,272 $3.37 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $93,697 - $104,869	-298 Reduced 83.24%	60 $21,000
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $84,402 - $96,283	298 Added 496.67%	358 $112,000
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $303,477 - $341,411	-1,062 Reduced 94.65%	60 $17,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $307,237 - $342,804	1,122 New	1,122 $324,000
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $911,303 - $1.02 Million	5,024 New	5,024 $911,000
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $640,850 - $717,163	-3,533 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $662,402 - $781,146	3,533 New	3,533 $712,000
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $57,344 - $66,842	-277 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $6,624 - $7,721	-32 Reduced 10.36%	277 $60,000
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $16,353 - $21,811	-79 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $63,966 - $85,311	309 New	309 $73,000
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $375,805 - $445,557	-1,470 Reduced 94.9%	79 $21,000
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $253,890 - $333,070	1,126 Added 266.19%	1,549 $450,000
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $163,212 - $202,460	-817 Reduced 65.89%	423 $101,000
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $264,235 - $354,897	-1,585 Reduced 56.11%	1,240 $271,000
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $469,433 - $528,342	2,824 Added 282400.0%	2,825 $478,000
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $640,497 - $740,729	-3,891 Reduced 99.97%	1 $0
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $511,480 - $647,171	3,367 Added 641.33%	3,892 $645,000
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $427,376 - $491,101	-2,548 Reduced 82.92%	525 $101,000
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $447,797 - $522,287	3,073 New	3,073 $522,000
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $897,472 - $1.05 Million	-5,920 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $812,697 - $920,856	5,920	5,920 $887,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account

Parallax Volatility Advisers, L.P. Vertex Pharmaceuticals Inc Transaction History